Wargenau, M.; Mutzke, E.; Spitzhorn, L.-S.; Reidemeister, S.; Klingmann, I.; Klingmann, V.
Survey Study to Identify the Maximum Acceptable Numbers of 2 mm and 3 mm Mini-Tablets for Short-, Middle-, and Long-Term Treatments in Acutely and Chronically Sick Children of Different Age Groups Below 18 Years. Pharmaceutics 2025, 17, 834.
https://doi.org/10.3390/pharmaceutics17070834
AMA Style
Wargenau M, Mutzke E, Spitzhorn L-S, Reidemeister S, Klingmann I, Klingmann V.
Survey Study to Identify the Maximum Acceptable Numbers of 2 mm and 3 mm Mini-Tablets for Short-, Middle-, and Long-Term Treatments in Acutely and Chronically Sick Children of Different Age Groups Below 18 Years. Pharmaceutics. 2025; 17(7):834.
https://doi.org/10.3390/pharmaceutics17070834
Chicago/Turabian Style
Wargenau, Manfred, Eva Mutzke, Lucas-Sebastian Spitzhorn, Sibylle Reidemeister, Ingrid Klingmann, and Viviane Klingmann.
2025. "Survey Study to Identify the Maximum Acceptable Numbers of 2 mm and 3 mm Mini-Tablets for Short-, Middle-, and Long-Term Treatments in Acutely and Chronically Sick Children of Different Age Groups Below 18 Years" Pharmaceutics 17, no. 7: 834.
https://doi.org/10.3390/pharmaceutics17070834
APA Style
Wargenau, M., Mutzke, E., Spitzhorn, L.-S., Reidemeister, S., Klingmann, I., & Klingmann, V.
(2025). Survey Study to Identify the Maximum Acceptable Numbers of 2 mm and 3 mm Mini-Tablets for Short-, Middle-, and Long-Term Treatments in Acutely and Chronically Sick Children of Different Age Groups Below 18 Years. Pharmaceutics, 17(7), 834.
https://doi.org/10.3390/pharmaceutics17070834
